Global Point of Care Coagulation Testing Products Market Size to Exceed USD 4.85 Billion By 2033 | CAGR of 6.98%
Category: HealthcareGlobal Point of Care Coagulation Testing Products Market Size to Exceed USD 4.85 Billion by 2033
According to a research report published by Spherical Insights & Consulting, the Global Point of Care Coagulation Testing Products Market Size is to grow from USD 2.47 Billion in 2023 to USD 4.85 Billion by 2033, at a Compound Annual Growth Rate (CAGR) of 6.98% during the projected period.
Get more details on this report -
Browse key industry insights spread across 230 pages with 125 Market data tables and figures & charts from the report on tthe report on the "Global Point of Care Coagulation Testing Products Market Size, Share, and COVID-19 Impact Analysis, By Type (Prothrombin Time Testing Products, Activated Clotting Time (ACT/APTT) Tesing Products, and Others), By Product Type (Instruments and Consumables), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/point-of-care-coagulation-testing-products-market
Point of care coagulation testing products are devices that measure the blood clotting parameters using small blood samples to diagnose the disorder. These tests play an important role in detecting bleeding disorders and monitoring anticoagulant drugs. There is a rising focus on early detection of blood-related diseases and increased research funding, awareness campaigns, and subsidies for vital medical devices such as point-of-care coagulation testing products. Healthcare professionals are more confident in using technologically advanced devices because of their increased accuracy and ease. The increasing prevalence of blood clotting disorders and rising incidence of cardiovascular illnesses and cancer emphasizes the need for point of care coagulation monitoring in patients. Further, the growing need for coagulation testing procedures due to the significant consumption of anticoagulant drugs is driving the market. The development of automated point of care coagulation testing products and rising government initiatives for suppressing blood-related diseases are propelling the market growth. On the contrary, the stringent regulatory frameworks and the high cost of POC analyzer products are restraining the global point of care coagulation testing products market.
The prothrombin time testing products segment dominates the market with the largest revenue share in 2023.
Based on type, the global point of care coagulation testing products market is segmented into prothrombin time testing products, activated clotting time (ACT/APTT) testing products, and others. Among these, the prothrombin time testing products segment dominates the market with the largest revenue share in 2023. Prothrombin time testing products are widely used in extrinsic factor deficiency screening and oral anticoagulant medication monitoring. These are used for the therapeutic monitoring of warfarin anticoagulant medication. The increasing use for the detection and diagnosis of various bleeding and excessive clotting disorders as well as monitoring the effectiveness of various anticoagulants are driving the market demand.
The instruments segment dominated the global point of care coagulation testing products market in 2023.
Based on the product type, the global point of care coagulation testing products market is segmented into instruments and consumables. Among these, the instruments segment dominated the global point of care coagulation testing products market in 2023. The technological advancements in coagulation testing instruments and their automation lead to several benefits such as high volume testing, better reproducibility, user flexibility, time and cost reduction, and better precision with quality controls. Further, the integration of electronic health records and the constant improvement in technologically advanced devices drive the market growth.
North America dominates the market with the largest market share over the forecast period.
Get more details on this report -
North America dominates the market with the largest market share over the forecast period. The increasing cases of hemophilia patients in the US and rising awareness about coagulation disorders are anticipated to drive the market demand. The growing emphasis on preventive healthcare and the capabilities of point of care coagulation testing products for facilitating the management of blood disorders are driving the market in the region. Further, the growing investments in R&D fueling the innovation of products in testing technology with high accuracy and efficiency are driving the market growth in the region.
Asia-Pacific region is expected to grow the fastest during the forecast period. The adoption of new technologies among hospitals and diagnostic laboratories is fueling the market growth. The introduction of advanced coagulation testing devices, an increase in healthcare expenditure, and changes in dynamics in the in vitro diagnostic industry are all factors responsible for driving the market in the region. Further, the adoption of new technologies among hospitals and diagnostic laboratories is fueling the market growth.
Major vendors in the global point of care coagulation testing products market are Abbott Laboratories, F. Hoffman-La Roche AG, Medtronic Plc., Siemens Healthcare AG, Koninklijke Philips N.V., HemoSonics, LLC, Haemonetics Corp, Werfen, Micropoint Bioscience, Inc., Helena Laboratories, ThermoFisher Sceintific Inc., Sysmex Corporation, Nihon Kohden Corporation, Alere Inc., and Other Key Players.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Developments
- In April 2024, HemoSonics, a medical device company focused on acute bleeding management, announced it had received Special 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the expanded use of arterial blood samples with its Quantra QStat Cartridge. HemoSonics’ QStat Cartridge used with the Quantra Hemostasis Analyzer first received 510(k) clearance from the U.S. FDA in 2022 for use in venous whole blood samples.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global point of care coagulation testing products market based on the below-mentioned segments:
Global Point of Care Coagulation Testing Products Market, Type Analysis
- Prothrombin Time Testing Products
- Activated Clotting Time (ACT/APTT) Testing Products
- Others
Global Point of Care Coagulation Testing Products Market, Product Type Analysis
- Instruments
- Consumables
Global Point of Care Coagulation Testing Products Market, Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- Uk
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?